Journal article
Effects of -Tocopherol and Mixed Tocopherol Supplementation on Markers of Oxidative Stress and Inflammation in Type 2 Diabetes
Clinical Chemistry, Vol.53(3), pp.511-519
03/2007
Abstract
Background: Vitamin E isomers may protect against atherosclerosis. The aim of this study was to compare the effects of supplementation with either α-tocopherol (αT) or mixed tocopherols rich in γ-tocopherol (γT) on markers of oxidative stress and inflammation in patients with type 2 diabetes. Methods: In a double-blind, placebo-controlled trial, 55 patients with type 2 diabetes were randomly assigned to receive (500 mg/day) (a) αT, (b) mixed tocopherols, or (c) placebo for 6 weeks. Cellular tocopherols, plasma and urine F 2-isoprostanes, erythrocyte antioxidant enzyme activities, plasma inflammatory markers, and ex vivo assessment of eicosanoid synthesis were analyzed pre-and postsupplementation. Results: Neutrophil αT and γT increased (both P <0.001) with mixed tocopherol supplementation, whereas αT (P <0.001) increased and γT decreased (P <0.005) after αT supplementation. Both αT and mixed tocopherol supplementation resulted in reduced plasma F 2-isoprostanes (P <0.001 and P = 0.001, respectively) but did not affect 24-h urinary F 2-isoprostanes or erythrocyte antioxidant enzyme activities. Neither αT nor mixed tocopherol supplementation affected plasma C-reactive protein, interleukin 6, tumor necrosis factor-α, or monocyte chemoattractant protein-1. Stimulated neutrophil leukotriene B 4 production decreased significantly in the mixed tocopherol group (P = 0.02) but not in the αT group (P = 0.15). Conclusions: The ability of tocopherols to reduce systemic oxidative stress suggests potential benefits of vitamin E supplementation in patients with type 2 diabetes. In populations with well-controlled type 2 diabetes, supplementation with either αT or mixed tocopherols rich in γT is unlikely to confer further benefits in reducing inflammation.
Details
- Title
- Effects of -Tocopherol and Mixed Tocopherol Supplementation on Markers of Oxidative Stress and Inflammation in Type 2 Diabetes
- Authors/Creators
- J.H.Y. Wu (Author/Creator) - The University of Western AustraliaN.C. Ward (Author/Creator) - School of Medicine and PharmacologyA.P. Indrawan (Author/Creator) - School of Medicine and PharmacologyC.M. Almeida (Author/Creator)J.M. Hodgson (Author/Creator) - School of Medicine and PharmacologyJ.M. Proudfoot (Author/Creator) - School of Medicine and PharmacologyI.B. Puddey (Author/Creator) - Faculty (United Kingdom)K.D. Croft (Author/Creator) - School of Medicine and Pharmacology
- Publication Details
- Clinical Chemistry, Vol.53(3), pp.511-519
- Publisher
- American Association for Clinical Chemistry Inc.
- Identifiers
- 991005540450707891
- Copyright
- © 2007 American Association for Clinical Chemistry.
- Murdoch Affiliation
- Centre for Clinical Immunology and Biomedical Statistics
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
34 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.68 Lipids
- 1.68.707 Oxidative Lipid Damage
- Web Of Science research areas
- Medical Laboratory Technology
- ESI research areas
- Clinical Medicine